Texas Permanent School Fund’s Catalyst Pharmaceutical CPRX Stock Holding History

Texas Permanent School Fund’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-97,747	Closed	-$1.56M	–	320
2024 Q1	$1.56M	Buy	97,747 +11,176	+13%	+$168K	0.01%	1165
2023 Q4	$1.46M	Buy	86,571 +1,483	+2%	+$20.3K	0.01%	1173
2023 Q3	$995K	Sell	85,088 -7,331	-8%	-$98.1K	0.01%	1250
2023 Q2	$1.24M	Buy	92,419 +10,122	+12%	+$146K	0.01%	1182
2023 Q1	$1.36M	Buy	82,297 +21,497	+35%	+$355K	0.01%	1130
2022 Q4	$1.13M	Sell	60,800 -7,233	-11%	-$111K	0.02%	1060
2022 Q3	$873K	Buy	+68,033	New	+$806K	0.01%	1156

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Texas Permanent School Fund's CPRX Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Catalyst Pharmaceutical (CPRX) in Q2 2024, closing a stake of 97,747 shares — an estimated $1.56M sold.

Texas Permanent School Fund first reported a position in CPRX in Q3 2022 and held it in 7 quarters. The position peaked at $1.56M in Q1 2024. 271 funds tracked by Wall St. Rank hold CPRX as of Q2 2024.

Texas Permanent School Fund reported no remaining Catalyst Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Texas Permanent School Fund sold 97,747 Catalyst Pharmaceutical shares in Q2 2024, an estimated $1.56M.
Texas Permanent School Fund first reported a position in Catalyst Pharmaceutical in Q3 2022 and held it in 7 quarters.
Texas Permanent School Fund's Catalyst Pharmaceutical position peaked at $1.56M in Q1 2024.
271 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.